
December 2021: Recurrent Endometrial Cancer: A Society of Gynecologic Oncology Podcast
12/09/21 • 33 min
Moderator:
Floor Backes, MD, Gynecologic Oncologist, The Ohio State University Comprehensive Cancer Center
Speakers:
Vicky Makker, MD, Medical Oncologist, Memorial Sloan Kettering Cancer Center
Matthew Powell, MD, Gynecologic Oncologist and Chief, Division of Gynecologic Oncology, Washington University School of Medicine Siteman Cancer Center
Amanda Nickles Fader, MD, Gynecologic Oncologist and Professor, Johns Hopkins School of Medicine
Description: Dr. Floor Backes is joined by Drs. Vicky Makker, Matthew Powell, and Amanda Nickles Fader to discuss best practices in utilizing molecular and pathologic tests to inform treatment of patients with recurrent metastatic endometrial cancer. The conversation begins with a patient case for the panelists’ discussion, followed by a series of scenarios to provide context for different considerations in the therapeutic regimen based on the patient’s molecular and sequencing results, histology, and response to treatment. This podcast was developed by the Society of Gynecologic Oncology for Gynecologic Oncology.
Additional Resources:
SGO ConnectEd: Chemotherapy & Targeted Therapy Flash Cards
Moderator:
Floor Backes, MD, Gynecologic Oncologist, The Ohio State University Comprehensive Cancer Center
Speakers:
Vicky Makker, MD, Medical Oncologist, Memorial Sloan Kettering Cancer Center
Matthew Powell, MD, Gynecologic Oncologist and Chief, Division of Gynecologic Oncology, Washington University School of Medicine Siteman Cancer Center
Amanda Nickles Fader, MD, Gynecologic Oncologist and Professor, Johns Hopkins School of Medicine
Description: Dr. Floor Backes is joined by Drs. Vicky Makker, Matthew Powell, and Amanda Nickles Fader to discuss best practices in utilizing molecular and pathologic tests to inform treatment of patients with recurrent metastatic endometrial cancer. The conversation begins with a patient case for the panelists’ discussion, followed by a series of scenarios to provide context for different considerations in the therapeutic regimen based on the patient’s molecular and sequencing results, histology, and response to treatment. This podcast was developed by the Society of Gynecologic Oncology for Gynecologic Oncology.
Additional Resources:
SGO ConnectEd: Chemotherapy & Targeted Therapy Flash Cards
Previous Episode

Looking Back at 2021: November Editor’s Choice
Hosted by:
Anil K. Sood, MD, MD Anderson Cancer Center
Featuring:
Tilley Jenkins Vogel, MD, Northshore University HealthSystem
Shannon N. Westin , MD, MPH, UT MD Anderson Cancer Center
Editor’s Choice Paper: Outcomes after targeted treatment based on somatic tumor genetic testing for women with gynecologic cancers
Editorial: Next generation sequencing for gynecologic malignancy: Promise and potential pitfalls
Next Episode

January 2022 Editor’s Choice: Optimizing Rural Ovarian Cancer Care
Hosted by:
David E. Cohn, MD, MBA, FACHE, Editor-in-Chief of Gynecologic Oncology
Featuring:
Kristin Weeks, MD/PhD candidate, University of Iowa
David Shalowitz , MD, MSHP, Wake Forest School of Medicine
Editor’s Choice Paper: Gynecologic oncologist impact on adjuvant chemotherapy care for stage II-IV ovarian cancer patients
Editorial: Defining the essential role of the gynecologic oncologist in rural ovarian cancer care delivery
If you like this episode you’ll love
Episode Comments
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/listen-to-gynecologic-oncology-618635/december-2021-recurrent-endometrial-cancer-a-society-of-gynecologic-on-81703241"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to december 2021: recurrent endometrial cancer: a society of gynecologic oncology podcast on goodpods" style="width: 225px" /> </a>
Copy